ResultsBusiness Standard
Gland Pharma Q2FY27 net profit rises 58% to Rs 290.75 crore
GreyOak summary
Gland Pharma reported a 58.29% increase in consolidated net profit to Rs 290.75 crore for the September quarter, driven by strong business execution. Revenue from operations grew to Rs 1,833.58 crore, while the company launched four new molecules in the US. Shares rose 0.70% on the BSE following the announcement.
What it affects
- Gland PharmaGLANDPositive +21
Net profit rose 58% to Rs 290.75 crore.Rolling sentiment Positive +64
Source
Read the original at Business StandardMore Gland Pharma news
- Five Stocks To Buy Today, November 11: Gland Pharma, Sansera Engineering, Union Bank, And MoreNDTV Profit · Stock view ·
- Gland Pharma shares rally 8% to hit 4-year-high post strong Q2Moneycontrol · Results ·
- Gland Pharma shares jump 7% to 52-week highCNBC-TV18 · Stock view ·
- Pharma shares shine: Sai, Gland, Divi's, Laurus, Glenmark surge up to 9%Business Standard · Stock view ·
- Divis, Gland, Sai Life Sciences shares hit 52-week highsBusiness Today · Stock view ·